Jiu Dian Pharmaceutical: Obtained the registration certificate for amlodipine tablets and ambroxol oral solution.

date
01/07/2026
Jiudian Pharmaceutical announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, involving two drugs, Nifedipine tablets and Ambroxol oral solution. Nifedipine tablets are used for the treatment of hypertension patients. As of the date of this announcement, a total of four domestic enterprises have obtained drug registration certificates for Nifedipine tablets. The company is the first domestic enterprise to pass or be deemed to have passed the evaluation of consistency in quality and efficacy of generic drugs; Ambroxol oral solution is commonly used to treat cough, thick phlegm, difficult expectoration, and wheezing caused by acute or chronic respiratory diseases.